Where are we in elimination of avoidable blindness after ten years of implementing 'VISION 2020 The Right to the sight' in Oman?
作者信息
Khandekar Rajiv
机构信息
Eye Health Care, Ministry of Health, Oman.
出版信息
Oman J Ophthalmol. 2012 May;5(2):73-4. doi: 10.4103/0974-620X.99366.
Abstract
摘要
相似文献
1
Where are we in elimination of avoidable blindness after ten years of implementing 'VISION 2020 The Right to the sight' in Oman?
Oman J Ophthalmol. 2012 May;5(2):73-4. doi: 10.4103/0974-620X.99366.
2
Vision 2020 - the right to sight.
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:3-5. doi: 10.1179/136485908X337409.
3
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
4
VISION 2020: the right to sight. A global initiative for the elimination of avoidable blindness.
Optometry. 2001 Oct;72(10):619-22.
5
The global initiative for the elimination of avoidable blindness - vision 2020: the right to sight.
Community Eye Health. 1999;12(30):32.
6
Current status of cataract blindness and Vision 2020: the right to sight initiative in India.
Indian J Ophthalmol. 2008 Nov-Dec;56(6):489-94. doi: 10.4103/0301-4738.42774.
7
Prevalence and causes of blindness & low vision; before and five years after 'VISION 2020' initiatives in Oman: a review.
Ophthalmic Epidemiol. 2007 Jan-Feb;14(1):9-15. doi: 10.1080/09286580600864802.
8
Vision 2020: where are we?
Curr Opin Ophthalmol. 2020 Mar;31(2):81-84. doi: 10.1097/ICU.0000000000000647.
9
VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness.
Arch Ophthalmol. 2004 Apr;122(4):615-20. doi: 10.1001/archopht.122.4.615.
10
Elimination of avoidable blindness due to cataract: where do we prioritize and how should we monitor this decade?
Indian J Ophthalmol. 2012 Sep-Oct;60(5):438-45. doi: 10.4103/0301-4738.100545.
引用本文的文献
1
Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment.
Middle East Afr J Ophthalmol. 2019 Aug 26;26(2):101-106. doi: 10.4103/meajo.MEAJO_113_17. eCollection 2019 Apr-Jun.
2
A vision for optometry in Oman.
Oman J Ophthalmol. 2013 May;6(2):75-6. doi: 10.4103/0974-620X.116617.
3
Ocular Genetics: A Sub-specialty Service for Genetic Eye Diseases.
Oman Med J. 2013 Jan;28(1):1-2. doi: 10.5001/omj.2013.01.
本文引用的文献
1
Oman Eye Study 2005: prevalence and determinants of glaucoma.
East Mediterr Health J. 2008 Nov-Dec;14(6):1349-59.
2
Vision 2020 - the right to sight.
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:3-5. doi: 10.1179/136485908X337409.
3
Prevalence and causes of blindness & low vision; before and five years after 'VISION 2020' initiatives in Oman: a review.
Ophthalmic Epidemiol. 2007 Jan-Feb;14(1):9-15. doi: 10.1080/09286580600864802.
4
Diabetic retinopathy in Oman: a hospital based study.
Br J Ophthalmol. 2003 Sep;87(9):1061-4. doi: 10.1136/bjo.87.9.1061.
5
The prevalence and causes of blindness in the Sultanate of Oman: the Oman Eye Study (OES).
Br J Ophthalmol. 2002 Sep;86(9):957-62. doi: 10.1136/bjo.86.9.957.
Zotero 插件